x
ServiziMenu principaleHome
Home > News > Interesting Articles

Interesting Articles


Breast implant-associated anaplastic large cell lymphoma - From diagnosis to treatment.
Kaartinen I, Sunela K, Alanko J, Hukkinen K, Karjalainen-Lindsberg ML, Svarvar C.
Eur J Surg Oncol. 2017 Aug;43(8):1385-1392

Review by Marjut Leidenius, MD
Department Head Breast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital.
A review of this article has been published in the Eusoma members'newsletter.

Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
Johnson L, O'Donoghue JM, McLean N, Turton P, Khan AA, Turner SD, Lennard A, Collis N, Butterworth M, Gui G, Bristol J, Hurren J, Smith S, Grover K, Spyrou G, Krupa K, Azmy IA, Young IE, Staiano JJ, Khalil H, MacNeill FA.
Eur J Surg Oncol. 2017 Aug;43(8):1393-1401

Review by Marjut Leidenius, MD
Department Head Breast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital.
A review of this article has been published in the Eusoma members'newsletter.

A clinical feasibility trial for identification of exceptional responders in whom breast cancer surgery can be eliminated following neoadjuvant systemic therapy.
Kuerer HM, Rauch GM, Krishnamurthy S, et al.
Ann Surg 2017, May 25. doi: 10.1097/SLA.0000000000002313.

Review by Isabel T. Rubio, MD
Breast Surgical Oncology, Hospital Universitario Vall d´Hebron, Barcelona, Spain
A review of this article has been published in the Eusoma members' newsletter.

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy
W. Fraser Symmans, Caimiao Wei, Rebekah Gould, et al.
JCO Jan 2017. DOI: 10.1200/JCO.2016.71.3503

Review by Prof. Peter Regitnig, MD
Institute of Pathology, Medical University of Graz, Austria
A review of this article has been published in the Eusoma members' newsletter.

5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trial
Vratislav Strnad, Oliver J Ott, Guido Hildebrandt, Daniela Kauer-Dorner, Hellen Knauerhase, Tibor Major, Jaroslaw Lyczek, Jose Luis Guinot, Jürgen Dunst, Cristina Gutierrez Miguelez, Pavel Slampa, Michael Allgäuer, Kristina Lössl, Bülent Polat, György Kovács, Arnt-René Fischedick, Thomas G Wendt, Rainer Fietkau, Marion Hindemith, Alexandra Resch, Anna Kulik, Leo Arribas, Peter Niehoff, Fernando Guedea, Annika Schlamann, Richard Pötter, Christine Gall, Martina Malzer, Wolfgang Uter, Csaba Polgár, on behalf of the Groupe Européen de Curiethérapie of European Society for Radiotherapy and Oncology (GEC-ESTRO)
Lancet. 2016 Jan 16;387(10015):229-38.

Review by Dr. Philip Poortmans
ESTRO President, Head of department of Radiation Oncology Radboud University Medical Center, Nijmegen, The Netherlands
A review of this article has been published in the Eusoma members' newsletter.

Outcome of a new patient pathway for managing B3 breast lesions by vacuum-assisted biopsy: time to change current UK practice?
C Strachan, K Horgan, R A Millican-Slater, A M Shaaban, N Sharma
JCP Online First, published on September 14, 2015

Review by
Robin Wilson
Head of the Breast Unit, The Royal Marsden Hospital, London, UK
Marjut Leidenius
Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland
A review of this article has been published in the Eusoma members'newsletter.

Performance of one-view breast tomosynthesis as a stand-alone breast cancer
Lång K, Andersson I, Rosso A, et al.
Eur Radiol DOI 10.1007/s00330-015-3803-3

Review by Prof. Per Skaane Dr. Med.
Department of Radiology, Oslo University Hospital Ullevaal,Norwey
A review of this article has been published in the Eusoma members' newsletter.